Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Florence Anthony A. Jr.
Relationship:  
City:   Chevy Chase
State:   MD
   
Insider Summary:
  
   
Companies Owned :   36    
Direct Shares   3,512,542    

Indirect Shares

   284,402,988      
Direct Value   $72,544    

Indirect Value

   $570,119,902      
Total Shares   287,915,530      
Total Value   $570,192,446      


Mersana Therapeutics, Inc. $8,763 Appian Corp $63,781 Mirum Pharmaceuticals, Inc. $0 Enliven Therapeutics Ord Shs $0 Mersana Therapeutics, Inc. $8,763 Appian Corp $63,781 Mirum Pharmaceuticals, Inc. $0 Enliven Therapeutics Ord Shs $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    5   
    3    

     Stock price went up :
    3   
    1    
     Stock price went down :
    2   
    2    
   
     Gain/Loss Ratio :
   1.5   
   1.5   
     Percentage Gain/Loss :
   38.2%
 148.6%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Interleukin Genetics Inc ILIU 10% Owner 0 2016-07-29 55,418,811    Premium*  
            Loxo Oncology, Inc. LOXO 10% Owner 2014-08-06 0 2014-08-06 1,789,420    Premium*  
            Tracon Pharmaceuticals, Inc. TCON 10% Owner 2015-02-04 0 2016-11-29 2,758,039    Premium*  
            Champions Biotechnology Inc CSBR 10% Owner 0 2015-03-11 18,750,000    Premium*  
            Ardelyx Inc ARDX 10% Owner 0 2019-12-09 6,564,372    Premium*  
            Nuvelo Inc ABIO 10% Owner 0 2018-02-26 0    Premium*  
            Synlogic Inc SYBX 10% Owner 2015-10-05 0 2018-01-26 4,228,940    Premium*  
            Avalo Therapeutics, Inc AVTX 10% Owner 2015-10-20 0 2015-10-20 594,245    Premium*  
            Adaptimmune Therapeutics PLC ADAP 10% Owner 0 2020-01-24 102,478,668    Premium*  
            Aveo Pharmaceuticals Inc AVEO 10% Owner 0 2022-10-19 354    Premium*  
            Achaogen Inc AKAO 10% Owner 0 2016-12-19 5,215,128    Premium*  
            Cascadian Therapeutics, Inc CASC 10% Owner 0 2018-03-09 0    Premium*  
            Mulesoft, Inc MULE 10% Owner 0 2018-05-01 0    Premium*  
            Mersana Therapeutics, Inc. MRSN 10% Owner 2020-09-14 3,210 2020-09-14 10,260    Premium*  
            Regulus Therapeutics Inc. RGLS 10% Owner 0 2020-12-04 6,451,056    Premium*  
            Surface Oncology, Inc. SURF 10% Owner 2018-04-23 0 2018-04-23 3,312,877    Premium*  
            Appian Corp APPN 10% Owner 2018-02-13 1,924 2018-02-13 13,895    Premium*  
            Genocea Biosciences, Inc. GNCA 10% Owner 2019-02-14 0 2022-05-25 0    Premium*  
            Trevi Therapeutics, Inc. TRVI 10% Owner 2019-05-09 0 2022-04-11 948,948    Premium*  
            Mirum Pharmaceuticals, Inc. MIRM 10% Owner 2023-06-13 384 2023-06-13 11,348    Premium*  
            Casper Sleep Inc. CSPR Director, 10% Owner 2022-01-25 0 2022-01-25 0    Premium*  
            Akouos, Inc. AKUS 10% Owner 2020-06-30 0 2022-11-30 0    Premium*  
            Nkarta, Inc. NKTX 10% Owner 2020-07-14 0 2020-07-14 2,902,115    Premium*  
            Inozyme Pharma, Inc. INZY 10% Owner 2020-07-28 0 2020-07-28 2,437,689    Premium*  
            Metacrine, Inc. MTCR 10% Owner 2020-09-18 0 2021-12-22 2,563,257    Premium*  
            Eargo, Inc. EAR 10% Owner 2020-10-20 0 2021-05-24 0    Premium*  
            Desktop Metal Ord Shs Class A DM 10% Owner 0 2021-06-08 806    Premium*  
            Savara Inc SVRA 10% Owner 0 2023-07-17 24,471,264    Premium*  
            Marker Therapeutics Inc MRKR 10% Owner 2021-03-16 0 2021-03-16 10,714,285    Premium*  
            Bright Health Group Inc. BHG 10% Owner 0 2021-06-28 23,983,073    Premium*  
            Monte Rosa Therapeutics, Inc. GLUE 10% Owner 2021-06-28 0 2021-06-28 7,692,298    Premium*  
            Robinhood Markets, Inc. HOOD Director 2021-08-02 0 2022-05-03 0    Premium*  
            Enliven Therapeutics Ord Shs ELVN 10% Owner 2022-01-06 3,507,024 2021-12-30 0    Premium*  
            Ionq Ord Shs IONQ 10% Owner 2022-11-16 0 2022-11-16 1,047    Premium*  
            Arcellx, Inc. ACLX 10% Owner 2022-12-20 0 2022-12-21 0    Premium*  
            Korro Bio KRRO 0 2024-04-22 1,090,793    Premium*  
* Premium Members only  

Records found :    168         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 4 of 7
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
MIRM Mirum Pharmaceuticals, In... 10% Owner   –       –       •   2023-06-13 4 A $0.00 $0 I/I 41,348 11,348 0 -
MIRM Mirum Pharmaceuticals, In... 10% Owner   –       –       •   2023-06-13 4 A $0.00 $0 D/D 384 384 0 -
MIRM Mirum Pharmaceuticals, In... 10% Owner   –       –       •   2023-06-13 4 D $0.00 $0 I/I (2,030,000) 0 0 -
GNCA Genocea Biosciences, Inc. 10% Owner   –       –       •   2022-05-24 4 S $0.07 $387,943 I/I (5,931,843) 4,445,093 0 -
GNCA Genocea Biosciences, Inc. 10% Owner   –       –       •   2022-05-25 4 S $0.08 $362,720 I/I (4,445,093) 0 0 -
ILIU Interleukin Genetics Inc 10% Owner   –       –       •   2014-12-23 4 B $0.10 $1,992,857 I/I 19,868,965 35,298,087 1.5 -
ILIU Interleukin Genetics Inc 10% Owner   –       –       •   2016-07-29 4 B $0.10 $2,000,000 I/I 20,120,724 55,418,811 1.5 -
GNCA Genocea Biosciences, Inc. 10% Owner   –       –       •   2019-02-14 4 B $0.47 $4,688,619 I/I 9,948,269 34,948,269 1.5 -
AVEO Aveo Pharmaceuticals Inc 10% Owner   –       –       •   2017-03-28 4 B $0.50 $3,000,000 I/I 6,000,000 16,362,694 1.5 -
ABIO Nuvelo Inc 10% Owner   –       –       •   2018-02-26 4 S $0.50 $731,273 I/I (1,460,209) 0 0 -
RGLS Regulus Therapeutics Inc. 10% Owner   –       –       •   2020-12-04 4 B $0.62 $2,735,930 I/I 4,398,602 6,451,056 1.5 %
ADAP Adaptimmune Therapeutics ... 10% Owner   –       –       •   2020-01-24 4 B $0.67 $5,000,250 I/I 7,500,000 19,500,000 1.5 %
ADAP Adaptimmune Therapeutics ... 10% Owner   –       –       •   2017-03-27 4 B $0.70 $9,009,000 I/I 12,870,000 72,139,000 1.5 -
MTCR Metacrine, Inc. 10% Owner   –       –       •   2021-12-22 4 S $0.91 $444,853 I/I (459,700) 2,563,257 0 -
RGLS Regulus Therapeutics Inc. 10% Owner   –       –       •   2019-05-07 4 B $1.08 $1,227,640 I/I 1,136,704 2,052,454 1.5 -
AVEO Aveo Pharmaceuticals Inc 10% Owner   –       –       •   2019-04-08 4 B $1.14 $4,956,523 I/I 4,347,827 25,243,865 1.5 -
MTCR Metacrine, Inc. 10% Owner   –       –       •   2021-12-10 4 S $1.32 $49,630 I/I (37,570) 3,022,957 0 -
AVEO Aveo Pharmaceuticals Inc 10% Owner   –       –       •   2018-12-21 4 B $1.49 $448,380 I/I 300,000 20,896,038 1.5 -
AVEO Aveo Pharmaceuticals Inc 10% Owner   –       –       •   2018-12-20 4 B $1.63 $326,060 I/I 200,000 20,596,038 1.5 -
ADAP Adaptimmune Therapeutics ... 10% Owner   –       –       •   2018-09-07 4 B $1.67 $25,000,500 I/I 15,000,000 12,000,000 1.5 -
MRKR Marker Therapeutics Inc 10% Owner   –       –       •   2021-03-16 4 B $1.75 $9,999,999 I/I 5,714,285 10,714,285 1.5 -
ADAP Adaptimmune Therapeutics ... 10% Owner   –       –       •   2018-03-21 4 B $1.81 $189,820 I/I 104,844 72,243,844 1.5 -
AVEO Aveo Pharmaceuticals Inc 10% Owner   –       –       •   2018-11-15 4 B $1.86 $631,958 I/I 340,000 19,038,038 1.5 -
AVEO Aveo Pharmaceuticals Inc 10% Owner   –       –       •   2018-11-16 4 B $1.86 $649,355 I/I 350,000 19,388,038 1.5 -
AVEO Aveo Pharmaceuticals Inc 10% Owner   –       –       •   2018-11-19 4 B $1.88 $956,658 I/I 510,000 19,898,038 1.5 -
  168  Records found
  1   2   3   4  5   6   7      
  Page 4 of 7  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us